hidden pixel

Indanylaminopropane Information

5-(2-Aminopropyl)-2,3-dihydro-1H-indene (5-APDI), also known as indanylaminopropane (IAP) and, incorrectly, as indanylamphetamine,[1] is an entactogen and psychedelic drug of the amphetamine family.[2][3] It has been sold by online vendors through the internet and has been encountered as a designer drug since 2003,[1][4][5] but its popularity has diminished in recent years.

5-APDI acts as a potent and weakly selective serotonin releasing agent (SSRA) with IC50 values of 82 nM, 1,848 nM, and 849 nM for inhibiting the reuptake of serotonin, dopamine, and norepinephrine, respectively.[2][3] It fully substitutes for MBDB but not amphetamine in trained animals, though it does produce disruption for the latter at high doses.[2]

Anecdotal reports suggest that 5-APDI is considerably less stimulating and euphoric than related compounds like MDMA.[4][5] However, in combination with amphetamine, it is said to be virtually indistinguishable from MDA by recreational users.[4][5]

See also

References

  1. ^ a b Casale JF, McKibben TD, Bozenko JS, Hays PA (2005). "Characterization of the "Indanylamphetamines"". Microgram Journal 3 (1–2): 3–10. http://www.usdoj.gov/dea/programs/forensicsci/microgram/journal_v3/mj05_v3_pg1.html.
  2. ^ a b c Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (November 1993). "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine". Journal of Medicinal Chemistry 36 (23): 3700–6. doi:10.1021/jm00075a027. PMID 8246240.
  3. ^ a b Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE (March 1998). "Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry 41 (6): 1001–5. doi:10.1021/jm9705925. PMID 9526575.
  4. ^ a b c "Bluelight Forums - The Big and Dandy Indanylaminopropane (IAP) Thread". http://www.bluelight.ru/vb/showthread.php?t=97013.
  5. ^ a b c "Erowid Experience Vaults - Indanylaminopropane (IAP)". http://www.erowid.org/experiences/subs/exp_IAP.shtml.

External links

Entactogens
Phenylalkylamines
Cyclized phenyl- alkylamines
Tryptamines
Others Naphthylisopropylamine
Hallucinogens
Psychedelics 5-HT2AR agonists
Dissociatives NMDAR antagonists
Deliriants mAChR antagonists
Miscellaneous
Cannabinoids CB1R agonists
D2R agonists * Also indirect D2 agonists such as dopamine reuptake inhibitors (cocaine, methylphenidate), releasing agents (amphetamine, methamphetamine), and precursors (levodopa).
GABAAR agonists
Inhalants Mixed MOA
κOR agonists
σR agonists
Others
Stimulants (N06B)
Adamantanes
Adenosine antagonists
Alkylamines
Arylcyclohexylamines
Benzazepines
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Piperazines
Piperidines
Pyrrolidines
Tropanes
Others
See also
Adrenergics
Receptor ligands
α1
α2
β
Reuptake inhibitors
NET
VMAT
Releasing agents
Enzyme inhibitors
Anabolism
PAH
TH
AAAD
DBH
PNMT
  • CGS-19281A
  • SKF-64139
  • SKF-7698
Catabolism
MAO
COMT
Others
Precursors
Cofactors
Others
List of adrenergic drugs
Dopaminergics
Receptor ligands
Agonists
Antagonists
Reuptake inhibitors
Plasmalemmal
DAT inhibitors
Vesicular
VMAT inhibitors
Releasing agents
Allosteric modulators
  • Quinazolinamines: SoRI-9804
  • SoRI-20040
  • SoRI-20041
Enzyme inhibitors
Anabolism
PAH inhibitors
TH inhibitors
AAAD/DDC inhibitors
Catabolism
MAO inhibitors
COMT inhibitors
DBH inhibitors
Others
Precursors
Cofactors
Others
List of dopaminergic drugs
Serotonergics
5-HT1 receptor ligands
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2 receptor ligands
5-HT2A
5-HT2B
5-HT2C
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Reuptake inhibitors
SERT
VMAT
Releasing agents
Enzyme inhibitors
Anabolism
TPH
AAAD
Catabolism
MAO
Others
Precursors
Cofactors
Others
Phenethylamines
Phenethylamines
Amphetamines Phenylisopropylamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines (and close relatives)
Miscellaneous

Categories:

 

The above information uses material from Wikipedia and is licensed under the GNU Free Documentation License.
Some facts may not have been fully verified for accuracy. [Disclaimers]
This page was last archived by our server on Fri May 11 16:51:02 2012.
Displaying this page or its contents does not use any Wikimedia Foundation's resources.
The owners of this site proudly support the Wikimedia Foundation.